Capula Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Capula Management's BMY Position: Q3 2026 in Review
Capula Management reduced its Bristol-Myers Squibb (BMY) stake by 20% in Q3 2026, selling an estimated $17.1K and leaving 1,102 shares worth $68.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1079.
Capula Management first reported a position in BMY in Q1 2020 and has held it in 18 quarters since. The position peaked at $16.2M in Q4 2022. 2,553 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Capula Management held 1,102 shares of Bristol-Myers Squibb worth $68.8K as of Q3 2026.
- Capula Management sold 271 Bristol-Myers Squibb shares in Q3 2026, an estimated $17.1K.
- Bristol-Myers Squibb made up ﹤0.01% of Capula Management's portfolio in Q3 2026, its #1079 holding.
- Capula Management first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 18 quarters since.
- Capula Management's Bristol-Myers Squibb position peaked at $16.2M in Q4 2022.
- 2,553 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Capula Management's 13F filing for Q3 2026, filed 16 Nov 2026.